McKinsey & Co. agreed to a $650 million settlement with the DOJ, resolving a criminal investigation into their role in advising Purdue Pharma on boosting OxyContin sales. A former McKinsey partner will plead guilty to obstruction of justice for destroying related records. McKinsey expressed regret for its past actions and agreed to improve compliance practices.
